NCCN 2024 Oncology Fellows Program: New Horizons in Quality Cancer Care

April 4, 2024

Designed specifically for oncology fellows, this half-day, CE-certified program seeks to educate future oncology practitioners about the application of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), the importance of communicating with patients and caregivers about difficult and sensitive topics, and preparing for entry into the oncology workforce.

Target Audience

This program is designed to meet the educational needs of second- and third-year medical, surgical, and radiation oncology fellows.

Learning Objectives

The goal of this activity is to ensure that oncology fellows, as members of the interprofessional oncology care team, have the knowledge and skills necessary to apply the standards of care to their practice and health care setting for patients with cancer.

Following this program, participants should be able to:

Global Learning Objectives
•   Evaluate advances in the treatment of patients with cancer and key updates in the NCCN Guidelines® and apply appropriate treatment and supportive care strategies to optimize patient education and care. 
•   Review issues related to the following topics: Health-Related Social Needs: How to Identify and Address the Needs of Your Patients; Health Insurance 101: Helping Patients Navigate the Health Insurance Maze; Difficult Conversations: How to Communicate with Patients and Caregivers; Team-Based Management of Immunotherapy-Related Toxicities; and Preparing to Launch: What You Need to Know (but no one ever told you) about Entering the Oncology Workforce.

Health-Related Social Needs: How to Identify and Address the Needs of Your Patients
•   Review the core measures of health-related social needs (HRSN).
•   Discuss how and when to screen patients for HRSN, barriers to screening, and how to discuss HRSN with patients and caregivers.
•   Describe the roles of other oncology care team members in addressing HRSN and the importance of educating patients and caregivers about these roles prior to referral.

Health Insurance 101: Helping Patients Navigate the Health Insurance Maze
•   Describe different insurance types and how coverage can affect patients with cancer and the treatment they receive.
•   Discuss potential insurance-related barriers and how to address them.
•   Identify advocacy organizations and members of the interprofessional oncology care team that help patients navigate health insurance issues.

Difficult Conversations: How to Communicate with Patients and Caregivers
•   Explain the importance of having difficult conversations with patients and caregivers and how these types of conversations can impact patient care.
•   Describe the differences between palliative, supportive, and hospice care and how to communicate with patients and caregivers about them.
•   Discuss resources that are available to patients and caregivers to help guide them in making difficult treatment decisions.

Team-Based Management of Immunotherapy-Related Toxicities
•   Describe the different classes of immunotherapies used for cancer treatment.
•   Recognize the toxicities that may occur with cancer immunotherapies.
•   Discuss multidisciplinary strategies to facilitate early diagnosis and treatment of immunotherapy-related toxicities.

Preparing to Launch: What You Need to Know (but no one ever told you) about Entering the Oncology Workforce
•   Incorporate practical skills that can be used to enhance career development and progression.
•   Describe common obstacles and pitfalls that may be faced in early career.
•   Explain key factors that will support a successful transition from fellow to attending physician.

Additional information
Supporters: 

Supported by educational grants from:

  • AstraZeneca
  • BeiGene
  • Coherus BioSciences
  • Genentech, a member of the Roche Group
  • Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Supported by independent medical educational grants from:

  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • GSK
  • Regeneron Pharmaceuticals, Inc.
Course summary
Available credit: 
  • 5.50 AMA PRA Category 1 Credit™
  • 5.50 Participation
Course opens: 
04/03/2024
Course expires: 
08/31/2024
Event starts: 
04/04/2024 - 12:30pm EDT
Event ends: 
04/04/2024 - 6:25pm EDT
Cost:
$0.00

NCCN Continuing Education Disclosure Policy
It is the policy of NCCN that all planners, faculty, moderators, authors, reviewers and anyone involved in the planning and delivery of NCCN continuing education activities are expected to disclose ALL financial relationships they have had in the past 24 months with ineligible companies. The ACCME Standards for Integrity and Independence require that individuals who refuse to provide this information will be disqualified from involvement in the planning and implementation of accredited continuing education presented by NCCN. NCCN identifies, mitigates and discloses to learners all relevant financial relationships.

In addition, all content has been reviewed to ensure education promotes safe, effective patient care and does not promote the products or services of an ineligible company. Content, including any presentation of therapeutic options, is fair, balanced, evidence-based, scientifically accurate, and free of commercial bias and marketing. 

Definitions  

Ineligible Company: An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

Relevant Financial Relationships: Financial relationships of any dollar amount occurring within the past 24 months are defined as relevant if the educational content an individual can control is related to the business lines or products of an ineligible company. There is no minimum financial threshold. We ask for disclosure of ALL financial relationships with ineligible companies, regardless of the amount and regardless of the potential relevance of each relationship to the education.

Faculty Disclaimers  

All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation for the tasks and methods of delivery.

Faculty presentations may include discussion of off-label use. Faculty will disclose that the use in question is not currently approved by the FDA per the product labeling or marketing.

Full disclosure of faculty relationships will be made prior to the activity.

image

In support of improving patient care, National Comprehensive Cancer Network (NCCN) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
NCCN designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 5.50 AMA PRA Category 1 Credit™
  • 5.50 Participation

Price

Cost:
$0.00
Please login or register to take this course.

Please log in with the same email address used for program registration.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
    • One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari
    • Internet Explorer is no longer supported
  • Adobe Reader or other PDF reader software for certificate viewing/printing